These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11304672)

  • 1. Surface grafting onto template-assembled synthetic protein scaffolds in molecular recognition.
    Fernandez-Carneado J; Grell D; Durieux P; Hauert J; Kovacsovics T; Tuchscherer G
    Biopolymers; 2000; 55(6):451-8. PubMed ID: 11304672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein design: on the threshold of functional properties.
    Tuchscherer G; Scheibler L; Dumy P; Mutter M
    Biopolymers; 1998; 47(1):63-73. PubMed ID: 9692327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein design as a challenge for peptide chemists.
    Tuchscherer G; Mutter M
    J Pept Sci; 1995; 1(1):3-10. PubMed ID: 9222979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo design of proteins. Template-assembled synthetic proteins (TASP).
    Tuchscherer G; Steiner V; Altmann KH; Mutter M
    Methods Mol Biol; 1994; 36():261-85. PubMed ID: 7697113
    [No Abstract]   [Full Text] [Related]  

  • 5. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
    Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
    Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intelligent design: the de novo engineering of proteins with specified functions.
    Koder RL; Dutton PL
    Dalton Trans; 2006 Jul; (25):3045-51. PubMed ID: 16786062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein design: template-assembled synthetic proteins.
    Carey RI; Altmann KH; Mutter M
    Ciba Found Symp; 1991; 158():187-99; discussion 199-203, 204-12. PubMed ID: 1935421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition with designed peptides and proteins.
    Cooper WJ; Waters ML
    Curr Opin Chem Biol; 2005 Dec; 9(6):627-31. PubMed ID: 16257571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond de novo protein design--de novo design of non-natural folded oligomers.
    Cheng RP
    Curr Opin Struct Biol; 2004 Aug; 14(4):512-20. PubMed ID: 15313247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal attachment position and linker length promote native-like character of cavitand-based template-assembled synthetic proteins (TASPs).
    Seo ES; Scott WR; Straus SK; Sherman JC
    Chemistry; 2007; 13(13):3596-605. PubMed ID: 17295367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ab initio prediction of the three-dimensional structure of a de novo designed protein: a double-blind case study.
    Klepeis JL; Wei Y; Hecht MH; Floudas CA
    Proteins; 2005 Feb; 58(3):560-70. PubMed ID: 15609306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein design with L- and D-alpha-amino acid structures as the alphabet.
    Durani S
    Acc Chem Res; 2008 Oct; 41(10):1301-8. PubMed ID: 18642934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-based design of novel protein structures.
    Butterfoss GL; Kuhlman B
    Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3- Instead of 4-helix formation in a de novo designed protein in solution revealed by small-angle X-ray scattering.
    Høiberg-Nielsen R; Tofteng Shelton AP; Sørensen KK; Roessle M; Svergun DI; Thulstrup PW; Jensen KJ; Arleth L
    Chembiochem; 2008 Nov; 9(16):2663-72. PubMed ID: 18850602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
    Rastegar-Lari G; Ajzenberg N; Ribba AS; Vereycken-Holler V; Legendre P; Villoutreix B; Meyer D; Baruch D
    Thromb Haemost; 2001 Dec; 86(6):1459-65. PubMed ID: 11776314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships.
    Gold ND; Jackson RM
    J Mol Biol; 2006 Feb; 355(5):1112-24. PubMed ID: 16359705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of artificial receptors into a protein/peptide surface: a strategy for on/off type of switching of semisynthetic enzymes.
    Hamachi I; Watanabe JI; Eboshi R; Hiraoka T; Shinkai S
    Biopolymers; 2000; 55(6):459-68. PubMed ID: 11304673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of proteins with molecular recognition capabilities using α3β3 de novo protein scaffolds.
    Okura H; Mihara H; Takahashi T
    Protein Eng Des Sel; 2013 Oct; 26(10):705-11. PubMed ID: 24046439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.